HIF2 Inhibitor Joins the Kidney Cancer Armamentarium

被引：16
|
作者：
Kaelin, William G., Jr. [1 ]
机构：
[1] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 09期
基金：
美国国家卫生研究院;
关键词：
RENAL-CELL CARCINOMA; HYPOXIA-INDUCIBLE FACTOR-2; LINDAU TUMOR-SUPPRESSOR; PAS-B DOMAIN; TRANSCRIPTION FACTOR; HIF2-ALPHA; INACTIVATION; HIF-2-ALPHA; ANTAGONIST; MICE;
D O I：
10.1200/JCO.2017.77.5254
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：908 / +
页数：5
相关论文
共 50 条
  • [1] THE HIF2α INHIBITOR BELZUTIFAN SHOWS SIGNS OF EFFICACY IN KIDNEY CANCER
    不详
    CANCER DISCOVERY, 2021, 11 (06) : 1319 - 1319
  • [2] Targeting acquired resistance to HIF2α inhibition in kidney cancer
    Zhao, Fangzhou
    Simon, Jeremy
    Zhang, Qing
    CANCER RESEARCH, 2023, 83 (16)
  • [3] On-Target Efficacy of a HIF2α Antagonist in Preclinical Kidney Cancer Models
    Kaelin, William
    FASEB JOURNAL, 2017, 31
  • [4] FDA OK's HIF2α Inhibitor Belzutifan
    Caruso, Catherine
    CANCER DISCOVERY, 2021, 11 (10) : 2360 - 2361
  • [5] Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs
    Arnaiz, Esther
    Miar, Ana
    Bridges, Esther
    Prasad, Naveen
    Hatch, Stephanie B.
    Ebner, Daniel
    Lawrie, Charles H.
    Harris, Adrian L.
    BMC CANCER, 2021, 21 (01)
  • [6] Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs
    Esther Arnaiz
    Ana Miar
    Esther Bridges
    Naveen Prasad
    Stephanie B. Hatch
    Daniel Ebner
    Charles H. Lawrie
    Adrian L. Harris
    BMC Cancer, 21
  • [7] The HIF2α puzzle
    Meera Swami
    Nature Reviews Cancer, 2010, 10 : 603 - 603
  • [8] Kidney development and gene expression in the HIF2α knockout mouse
    Steenhard, Brooke Al.
    Freeburg, Paul B.
    Isom, Kathryn
    Stroganova, Larysa
    Borza, Dorin-Bogdan
    Hudson, Billy G.
    John, Patricia L. St.
    Zelenchuk, Adrian
    Abrahamson, Dale R.
    DEVELOPMENTAL DYNAMICS, 2007, 236 (04) : 1115 - 1125
  • [9] Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang Syndrome
    Kamihara, Junne
    Hamilton, Kayla V.
    Pollard, Jessica A.
    Clinton, Catherine M.
    Madden, Jill A.
    Lin, Jasmine
    Imamovic, Alma
    Wall, Catherine B.
    Wassner, Ari J.
    Weil, Brent R.
    Heeney, Matthew M.
    Vargas, Sara O.
    Kaelin, William G., Jr.
    Janeway, Katherine A.
    Perini, Rodolfo F.
    Zojwalla, Naseem J.
    Voss, Stephan D.
    DuBois, Steven G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (22): : 2059 - 2065
  • [10] HYPOXIA The HIF2α puzzle
    Swami, Meera
    NATURE REVIEWS CANCER, 2010, 10 (09) : 603 - 603
12345